Kimberly Brannen

Merck & Co.

Kimberly Brannen is listed at Merck & Co.. Kimberly is scheduled to speak at SOT 66th Annual Meeting and ToxExpo 2027 on 16 March 2027.

Compiled from published conference agendas; not yet confirmed by Kimberly. Is this you? Claim this profile.

Upcoming

SOT 66th Annual Meeting and ToxExpo 2027 14 March 2027 – 17 March 2027

• Applying Developmental Toxicity NAMs in Pharmaceutical Development: Building Regulatory Credibility Speaker · 16 March 2027
• Rethinking DART Testing: Advancing Dev Tox NAMs Through Stakeholder Dialogue Speaker · 16 March 2027

Spoke alongside

People who have shared a session with Kimberly at events on B2DB.

• Connie Chen HESI;HESI Global 1 shared session
• Fumito Mikashima Pharmaceuticals and Medical Devices Agency 1 shared session
• Julia Boos Swiss Centre for Applied Human Toxicology 1 shared session
• Peter Theunissen Medicines Evaluations Board 1 shared session
• Sarah Obican University of South Florida 1 shared session